Kim, Oliver

Kim, Oliver was paid $2.05M by Medicaid between Jan 2018 and Nov 2024, across 125 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 9.9% of everything it billed.

Compared with peers

Next to other Anatomic Pathology & Clinical Pathology Physician providers in Illinois

Rank by total paid#35 of 398

Median peer was paid$66K

This provider vs. median31×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	20,337	$85K
2019	23,778	$114K
2020	159,225	$761K
2021	61,934	$468K
2022	36,428	$279K
2023	33,066	$189K
2024incomplete	29,875	$149K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	9.9%	3,462	2,814	$203K
80053	Comprehensive metabolic panel	9.8%	41,182	24,228	$201K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	7.9%	56,125	29,154	$162K
83735		5.6%	28,392	12,209	$115K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	5.6%	4,813	4,096	$114K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	4.9%	1,339	1,268	$101K
80048	Basic metabolic panel (calcium, ionized)	4.5%	21,770	9,350	$92K
87040		3.9%	9,500	7,138	$80K
88305	Level IV - Surgical pathology, gross and microscopic examination	3.7%	1,648	1,556	$75K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	3.5%	2,673	2,063	$72K
84484		2.5%	11,739	7,699	$52K
83605		2.2%	9,861	7,126	$46K

113 more codes

87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	2.1%	1,935	$42K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	2.0%	251	$42K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	1.9%	4,904	$38K
84443	Thyroid stimulating hormone (TSH)	1.7%	4,281	$35K
87086	Culture, bacterial; quantitative colony count, urine	1.7%	6,448	$35K
85730		1.5%	9,692	$32K
83690		1.5%	8,700	$31K
84100		1.5%	11,256	$30K
85027		1.3%	8,811	$27K
83880		1.3%	2,481	$27K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	1.3%	761	$26K
85610		1.2%	12,398	$25K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	1.1%	2,370	$24K
85379		<1%	4,099	$16K
86850		<1%	5,464	$16K
86901		<1%	6,603	$15K
81001		<1%	10,162	$15K
82803		<1%	1,670	$14K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	562	$13K
87081		<1%	4,598	$13K
86900		<1%	6,608	$11K
86140		<1%	5,071	$11K
84703		<1%	2,381	$8K
82728		<1%	2,197	$8K
87641		<1%	343	$8K
80076		<1%	2,229	$8K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	139	$7K
87493		<1%	314	$7K
80061	Lipid panel	<1%	2,023	$7K
83615		<1%	2,340	$6K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	283	$6K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	276	$6K
82550		<1%	1,609	$6K
83036	Hemoglobin; glycosylated (A1C)	<1%	1,646	$5K
88342		<1%	438	$5K
87070		<1%	1,324	$5K
82247		<1%	1,890	$5K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	124	$4K
81003		<1%	3,920	$4K
82607		<1%	708	$4K
87075		<1%	588	$4K
82077		<1%	237	$4K
84439		<1%	854	$3K
84702		<1%	774	$3K
80202		<1%	468	$3K
87088		<1%	512	$3K
82248		<1%	1,370	$3K
87205		<1%	1,511	$3K
82746		<1%	476	$3K
81025		<1%	1,338	$3K
85652		<1%	2,129	$2K
83550		<1%	604	$2K
85018		<1%	1,933	$2K
82150		<1%	435	$2K
87186		<1%	342	$2K
87077		<1%	523	$2K
83516		<1%	230	$2K
85384		<1%	584	$2K
82140		<1%	475	$2K
85014		<1%	1,615	$2K
87340		<1%	282	$2K
80074		<1%	96	$2K
82570		<1%	627	$2K
89051		<1%	471	$2K
86880		<1%	533	$2K
86803		<1%	168	$1K
86706		<1%	204	$1K
84145		<1%	1,249	$1K
86480		<1%	51	$1K
85046		<1%	465	$1K
86704		<1%	99	$1K
87015		<1%	314	$1K
80143		<1%	68	$1K
80179		<1%	65	$1K
84132		<1%	438	$954.84
82330		<1%	130	$875.08
87807		<1%	173	$824.14
83655		<1%	135	$812.41
86870		<1%	107	$788.70
84478		<1%	328	$703.21
84550		<1%	450	$698.63
84300		<1%	251	$591.48
82010		<1%	162	$538.18
82747		<1%	81	$537.84
82962		<1%	599	$503.86
84156		<1%	429	$474.94
83930		<1%	181	$470.23
88304		<1%	22	$469.09
87449		<1%	58	$454.72
87806		<1%	46	$443.40
83935		<1%	182	$417.07
86038		<1%	52	$399.75
87045		<1%	58	$356.70
86769		<1%	16	$347.65
87427		<1%	58	$306.25
80164		<1%	55	$276.29
86592		<1%	133	$258.70
80069		<1%	55	$224.35
87102		<1%	69	$220.22
84157		<1%	143	$193.90
80320		<1%	1,722	$168.75
82945		<1%	99	$154.00
86665		<1%	13	$138.40
82947		<1%	45	$135.32
87046		<1%	71	$123.12
80177		<1%	22	$105.81
82105		<1%	13	$98.52
87206		<1%	44	$84.00
84481		<1%	14	$67.48
83540		<1%	15	$47.85
86923		<1%	265	$21.00
85461		<1%	12	$18.96
80329		0%	394	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.